LCA activity
Recent labor-condition rows help reveal roles, worksites, wages, and case statuses. LCA certification is not USCIS petition approval.
Imported LCA rows
16
Median wage
$166,645
Source period
FY2026 Q2
H-1B/LCA filing signal: As of source verification 2026-06-25, Alexion Pharmaceuticals shows 16 imported DOL labor-condition rows through FY2026 Q2 on VisaSignal. The largest role bucket is Associate Director, Commercial Data Analytics and Reporting (3 rows). The largest worksite bucket is Boston, MA (9 rows). Treat this as historical H-1B/LCA filing activity, not proof of USCIS petition approval or future sponsorship.
Wage range
Normalized from 16 imported LCA wage rows. DOL-disclosed offered and prevailing wages span different roles, worksites, and wage units — read the band as wage-distribution context, not a guaranteed offer or legal minimum.
25th percentile
$159,318
Median
$166,645
75th percentile
$171,827
Range
$106,605 – $201,058
H-1B evidence checklist
For searches like "Alexion Pharmaceuticals H-1B", "Alexion Pharmaceuticals LCA", or "does Alexion Pharmaceuticals sponsor H-1B", read the filing count, role/worksite pattern, and status mix together before treating the employer as a lead.
For "Alexion Pharmaceuticals H-1B" or "Alexion Pharmaceuticals LCA" research, 16 imported DOL LCA rows through FY2026 Q2 show labor-condition activity attributed to this normalized employer name. Use the count as a historical filing signal, not a hiring promise.
Read source caveatsAssociate Director, Commercial Data Analytics and Reporting (3 rows) and Boston, MA (9 rows) are the strongest role and worksite signals. Compare those row-level patterns with the wage band before treating Alexion Pharmaceuticals as relevant to your target role or location.
Compare salary signalsCertified represents 100% of the displayed LCA rows. DOL LCA certification is not USCIS H-1B petition approval, so read the status mix with row dates and source period before treating Alexion Pharmaceuticals as a sponsor lead. Then compare the employer against the broader H-1B sponsor database before shortlisting.
Browse H-1B sponsorsUse the full LCA and PERM database lookup when you need to search Alexion Pharmaceuticals rows across job titles, SOC codes, worksites, and states instead of relying only on this employer summary.
Open LCA database lookupLCA query context
For searches like "Alexion Pharmaceuticals LCA", start with the official filing count, then compare role, worksite, wage, and status signals before opening individual rows.
Associate Director, Commercial Data Analytics and Reporting is the largest imported role bucket with 3 matching rows.
Boston, MA is the largest imported worksite cluster with 9 matching rows.
See other H-1B sponsors in Massachusetts.
Certified is the largest observed case-status bucket, representing 100% of 16 displayed LCA rows.
Status mix is the share of displayed official DOL LCA rows by case outcome; for Alexion Pharmaceuticals, Certified accounts for 100% of the recent LCA rows shown here as of source verification .
| Case | Status | Decision | Role | Worksite | Wage | Source |
|---|---|---|---|---|---|---|
| I-200-26078-717124 | Certified | Mar 26, 2026 | Scientist II, Injectable Drug Product Development | New Haven, CT | $142,766 | FY2026 Q2 |
| I-200-26021-577675 | Certified | Jan 28, 2026 | Associate Director, Commercial Data Analytics and Reporting | Boston, MA | $161,803 | FY2026 Q2 |
| I-200-25345-475592 | Certified | Dec 18, 2025 | Associate Director, Commercial Data Analytics and Reporting | Boston, MA | $201,058 | FY2026 Q1 |
| I-200-25345-475874 | Certified | Dec 18, 2025 | Global/US Market Research & CI Partner | Boston, MA | $166,842 | FY2026 Q1 |
| I-200-25345-475592 | Certified | Dec 18, 2025 | Associate Director, Commercial Data Analytics and Reporting | Boston, MA | $201,058 | FY2026 Q2 |
| I-200-25345-475874 | Certified | Dec 18, 2025 | Global/US Market Research & CI Partner | Boston, MA | $166,842 | FY2026 Q2 |
| I-200-25329-438682 | Certified | Dec 3, 2025 | Associate Director, Research Collaborations and Alliances | Boston, MA | $169,770 | FY2026 Q2 |
| I-200-25329-438418 | Certified | Dec 3, 2025 | Associate Director, Data Operations & Data Quality | New Haven, CT | $178,000 | FY2026 Q1 |
| I-200-25329-438682 | Certified | Dec 3, 2025 | Associate Director, Research Collaborations and Alliances | Boston, MA | $169,770 | FY2026 Q1 |
| I-200-25329-438418 | Certified | Dec 3, 2025 | Associate Director, Data Operations & Data Quality | New Haven, CT | $178,000 | FY2026 Q2 |
| I-200-25329-434854 | Certified | Dec 2, 2025 | Manager, Biostatistics | Boston, MA | $159,318 | FY2026 Q2 |
| I-200-25329-434854 | Certified | Dec 2, 2025 | Manager, Biostatistics | Boston, MA | $159,318 | FY2026 Q1 |
| I-200-25321-413826 | Certified | Nov 24, 2025 | Sr. Mgr., Global Med Affairs Business Ops Partner | New Haven, CT | $166,448 | FY2026 Q1 |
| I-200-25321-413826 | Certified | Nov 24, 2025 | Sr. Mgr., Global Med Affairs Business Ops Partner | New Haven, CT | $166,448 | FY2026 Q2 |
| I-200-25316-400362 | Certified | Nov 19, 2025 | PDCS Compliance Specialist | New Haven, CT | $106,605 | FY2026 Q2 |
| I-200-25316-400362 | Certified | Nov 19, 2025 | PDCS Compliance Specialist | New Haven, CT | $106,605 | FY2026 Q1 |
Related sponsors
Employers with imported DOL LCA or PERM filings that also list Massachusetts worksites, weighted toward overlapping roles. Shared filing footprints are a research and discovery signal, not a hiring or sponsorship guarantee.
Primary source
LCA rows for Alexion Pharmaceuticals are imported from DOL OFLC LCA Disclosure Data, the official US Department of Labor disclosure dataset. See About data for source caveats and Source status for import freshness, or use the LCA and PERM database lookup to search records across employers, roles, SOC codes, cities, and states. To check whether a different company sponsors H-1B, run it through the H-1B sponsor checker or review the H-1B sponsor cost guide.
DOL OFLC performance pageDate retrieved: . Last verified: . Page updated: .
FAQ
The Alexion Pharmaceuticals LCA page summarizes imported Department of Labor labor-condition rows for this normalized employer, including roles, worksites, wages, case statuses, and source periods.
No. LCA certification is an official DOL labor-condition filing signal, but USCIS decides H-1B petitions separately. Use the page as employer research context, not as an approval record.
Searches like "Alexion Pharmaceuticals H-1B" or "Alexion Pharmaceuticals H-1B sponsor" are best read against this LCA filing activity, which reflects historical labor-condition signals at Alexion Pharmaceuticals. It is not a promise of future sponsorship or an indicator of any individual case outcome.
Yes. This Alexion Pharmaceuticals LCA lookup view shows imported official DOL labor-condition rows for the employer, including job titles, worksites, wage fields, case statuses, and source periods. For a broader LCA lookup across employers, roles, SOC codes, cities, and states, use the LCA and PERM database lookup.
For searches like "Alexion Pharmaceuticals H-1B salary", VisaSignal normalizes the imported LCA wage fields into a range — the 25th-to-75th-percentile band plus the lowest and highest observed values — instead of a single number. These are DOL-disclosed offered and prevailing wages spanning different roles, worksites, and wage units, so read the band as wage-distribution context, not a guaranteed offer or legal minimum.
No. A DOL-certified LCA is not the same as USCIS H-1B petition approval. It is an official labor-condition filing signal that should be interpreted with that limit.
No. PERM certification is one step in an employment-based green card process. It does not mean a green card, I-140 petition, or adjustment of status was approved.
No. Official filing history can show recent activity, roles, worksites, and wage signals, but it does not guarantee future sponsorship or predict legal outcomes.
LCA and PERM rows are filing signals, not USCIS approvals, green-card approvals, legal advice, or outcome predictions.